<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Long-circulating submicron <z:chebi fb="23" ids="18059">lipid</z:chebi> emulsions, stabilized with <z:chebi fb="0" ids="46793">poly(ethylene glycol)</z:chebi>-modified <z:chebi fb="0" ids="16038">phosphatidylethanolamine</z:chebi> (<z:chebi fb="77" ids="46793">PEG</z:chebi>-PE), are promising drug carriers with substantial capacity for solubilization of lipophilic anticancer agents </plain></SENT>
<SENT sid="1" pm="."><plain>This study describes the conjugation of the anti-B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> monoclonal antibody LL2 to the surface of <z:chebi fb="23" ids="18059">lipid</z:chebi>-emulsion globules by use of a novel <z:chebi fb="0" ids="46793">poly(ethylene glycol)</z:chebi>-based heterobifunctional coupling agent </plain></SENT>
<SENT sid="2" pm="."><plain>The efficiency of coupling of LL2 to the <z:chebi fb="23" ids="18059">lipid</z:chebi> emulsion was 85% (approx.) and essentially independent of the LL2/emulsion particle ratio and amount of surface-bound <z:chebi fb="77" ids="46793">PEG</z:chebi>-PE </plain></SENT>
<SENT sid="3" pm="."><plain>Results from <z:chebi fb="27" ids="17992">sucrose</z:chebi>-gradient centrifugation and <z:chebi fb="0" ids="2511">Sepharose</z:chebi> CL-4B gel filtration indicated stable binding of the antibody to the emulsion </plain></SENT>
<SENT sid="4" pm="."><plain>The immunoreactivity of the emulsion-LL2 conjugates was tested with alkaline phosphatase-conjugated LL2 against a monoclonal anti-idiotype antibody, WN </plain></SENT>
<SENT sid="5" pm="."><plain>The binding of the conjugates to WN increased with increasing surface density of LL2 up to 40 monoclonal antibodies/emulsion particle, and exceeded that for the free monoclonal antibody (approx </plain></SENT>
<SENT sid="6" pm="."><plain>20 molecules/particle) </plain></SENT>
<SENT sid="7" pm="."><plain>Results from competitive-binding ELISA were indicative of similar displacement curves for free LL2 and emulsion-LL2 conjugates </plain></SENT>
<SENT sid="8" pm="."><plain>Direct cellular ELISA revealed similar binding of emulsion-LL2 complexes to three types of Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell lines, Raji, Ramos and Daudi </plain></SENT>
<SENT sid="9" pm="."><plain>The results from this study indicate that emulsion-LL2 complexes might be a useful drug-carrier system for more specific delivery of anticancer drugs to B-cell <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
</text></document>